Skip to main content
Aditya Bagrodia on Muck Rack

Aditya Bagrodia

As seen in: Environmental Health Perspectives, Color Research & Application, Nature, Wiley, Medscape, Newswise, medRxiv, ONCOLOGY journal, European Urology, UroToday and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Aditya

Contact Aditya, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Re: Primary Retroperitoneal Lymph Node Dissection in Marker Positive Clinical Stage II Non-Seminomatous Germ Cell Tumours

|
By Benjamin A. Baker, Margaret F. Meagher, Giacomo Musso, Aditya Bagrodia, Sarah Azari, Fred Millard
| European Urology Verified
Get full text access Log in, subscribe or purchase for full access. References 1. Tachibana, I. ∙ Kern, S.Q. ∙ Douglawi, A. ... Primary retroperitoneal lymph node dissection for patients with pathologic stage II nonseminomatous germ cell tumor–N1, N2, and N3 disease: is adjuvant chemotherapy necessary? J Clin Oncol. 2022; 40:3762-3769 2. Donohue, J.P. ∙ Thornhill, J.A. ∙ Foster, R.S. ...
Open in Who Shared Issue with article?

Primary retroperitoneal lymph node dissection in clinical stage 2a/b non‐seminomatous germ cell tumour

|
By Luca Antonelli, Axel Heidenreich, Aditya Bagrodia, Fady Baky, Nicolas Branger, Walter Cazzaniga, Timothy N. Clinton, Siamak Daneshmand, Hooman Djaladat, Scott Eggener, Alireza Ghoreifi, Robert Hamilton, Matthew Ho, Wade J. Sexton, Armon Amini
| BJU International Journal Verified
Supporting Information Filename Description bju16618-sup-0001-Supplementaryfile1.docxWord 2007 document , 1 MB File S1. Data analysis excluding the main contributing centre. bju16618-sup-0002-Supplementaryfigure1.docxWord 2007 document , 438 KB Figure S1. Kaplan–Meier estimates of disease-free survival (DFS), stratified by number of cycles of adjuvant chemotherapy. bju16618-sup-0003-Supplementarytable1.docxWord 2007 document , 27.4 KB Table S1.
Open in Who Shared Issue with article?

Advanced Restriction imaging and reconstruction Technology for Prostate MRI (ART-Pro): Study protocol for a multicenter, multinational trial evaluating biparametric MRI and advanced, quantitative diffusion MRI for detection of prostate cancer

|
By Madison T Baxter, Christopher C. Conlin, Aditya Bagrodia, Tristan Barrett
| medRxiv
Abstract Background: Multiparametric MRI (mpMRI) is strongly recommended by current clinical guidelines for improved detection of clinically significant prostate cancer (csPCa). However, major limitations of mpMRI are the need for intravenous (IV) contrast and dependence on reader expertise. Efforts to address these issues include use of biparametric MRI (bpMRI) and advanced, quantitative MRI techniques.
Open in Who Shared Issue with article?
See all 27 licensed articles (30 Total)